A US government advisory panel has recommended emergency approval for the Pfizer-BioNTech coronavirus vaccine, underlining that the shot’s potential benefits outweigh its risks. After an eight-hour public hearing on Thursday, the Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted 17 to 4 with 1 abstention to recommend the vaccine developed by Pfizer and its German partner BioNTech.from IndiaTV India: Google News Feed https://ift.tt/2W9Q0rj
via
No comments:
Post a Comment
Please do not enter spam link in the comment box. Suggestions are invited for improvement.